Skip to content

Author

Maryam Karimi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Longitudinal Economic Burden for Non–Muscle-Invasive Bladder Cancer by EAU Progression Risk Groups Using the Prospective Multicenter COBLAnCE Cohort Linked to the French National Healthcare System Database

Take Home Message Costs of non-muscle invasive bladder cancer are highly heterogeneous and strongly influenced by disease severity and early treatment. Real-world, stage-specific estimates are essential for informing cost-effectiveness analyses and guiding health care decision-making.

A. Fraslin, S. Benhamou, Thierry Lebret et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.